Marc Miquel Moltó Abad I am a biologist with experience in both clinical and preclinical research on lysosomal storage diseases. I am intrigued by the clinical complexity of these rare diseases. Their low incidence in the population, the limited knowledge about their pathophysiology and the limitations of their current treatment are important points that needs to be investigated. I am very interested in nanotechnology application as a tool to improve the treatment of these diseases as well as the life quality of these patients. Institutions of which they are part Predoctoral researcher Basic, Translational and Clinical Pharmacy Research Vall Hebron Institut de Recerca LinkedIn Twitter Orcid Marc Miquel Moltó Abad LinkedIn Twitter Orcid Institutions of which they are part Predoctoral researcher Basic, Translational and Clinical Pharmacy Research Vall Hebron Institut de Recerca I am a biologist with experience in both clinical and preclinical research on lysosomal storage diseases. I am intrigued by the clinical complexity of these rare diseases. Their low incidence in the population, the limited knowledge about their pathophysiology and the limitations of their current treatment are important points that needs to be investigated. I am very interested in nanotechnology application as a tool to improve the treatment of these diseases as well as the life quality of these patients.
I have experience in cell culture, in vitro and in vivo assays and the monitoring of clinical trials. Regarding basic research, I have participated in projects ranging from the field of cancer and telomere dysfunction, to projects about the study of nanoparticles application in order to improve the treatment of a rare metabolic disease (Fabry's disease). In 2013 I got my Biology’s degree from the Universitat Autònoma de Barcelona and in 2015 I completed an official master's degree in Cytogenetics and Reproductive Biology at the same university where I was able to work on my cell culture skills (derivative publication in Oncotarget). Subsequently, I started to work as a research technician in the Rare Diseases Unit of the Vall d'Hebron University Hospital in Barcelona (2016-2019), where I collaborated in the coordination of research projects and clinical trials focused on a group of rare diseases called lysosomal storage diseases. Consequently, I am a co-author of different scientific publications (8), in specialized journals (Mol Genet Metab, J Clin Med, Orphanet J Rare Dis, J Bone Min Res). In 2020, I began my journey as a predoctoral researcher in the Delivery and Targeting research group testing nanometric systems for the improvement of current treatment of Fabry disease. As a result, I am a co-author of a review paper (WIRES) and a scientific publication (J Extracel Ves).
